Evidence map›Paper›PMID 28004176›Full record

Observational studyHeart and vessels2017

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.

Florian Blachutzik, Niklas Boeder, Jens Wiebe, Alessio Mattesini, Oliver Dörr, Astrid Most, Timm Bauer, Monique Tröbs, Jens Röther, Christian Schlundt and 3 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Heart and vessels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Florian BlachutzikFriedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany. florian.blachutzik@uk-erlangen.de.ORCID http://orcid.org/0000-0002-7695-3663
Niklas BoederJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.
Jens WiebeGerman Heart Centre Munich, Munich, Germany.
Alessio MattesiniCareggi Hospital, Florence, Italy.
Oliver DörrJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.
Astrid MostJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.
Timm BauerJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.
Monique TröbsFriedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.
Jens RötherFriedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.
Christian SchlundtFriedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.
Stephan AchenbachFriedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.
Christian HammJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.
Holger NefJustus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overlapping implantation of bioresorbable vascular scaffolds is frequently necessary, but its influence on vessel and scaffold structure has not been thoroughly analyzed previously. The aim of this study was to analyze the acute effects of overlapping implantation on BRS as determined by optical coherence tomography (OCT). A total of 38 patients with de novo coronary artery stenoses who underwent OCT in the context of implantation of novolimus-eluting BRS (DESolve, Elixir Medical Corporation, Sunnyvale, California, USA) were investigated. In 15 patients, overlapping implantation of two BRS was performed, while 23 patients with implantation of one single BRS served as the control group. OCT data were retrospectively analyzed regarding acute scaffold implantation results. There were no significant differences between the overlap and control group in terms of residual in-scaffold area stenosis, scaffold area, mean or minimal lumen area, eccentricity index, incomplete scaffold apposition area or malapposition. While strut fracture was slightly more frequent in BRS with overlap its incidence was low overall. In patients with overlapping BRS, overlap segments did not display smaller lumen areas than segments without overlap (mean lumen area overlap: 8.16 ± 2.97 mm

Indexed as

Absorbable ImplantsTissue ScaffoldsAgedCoronary AngiographyCoronary StenosisEverolimusFemaleGermanyHumansMacrolidesMaleMiddle AgedPercutaneous Coronary InterventionRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeEverolimusMacrolidesnovolimusBioresorbable ScaffoldOptical coherence tomographyPercutaneous coronary intervention

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.